Pharmacy

Valeant Pharmaceuticals on Monday said it will offer hospitals deeper discounts for the heart drugs Nitropress and Isuprel, with hospitals now eligible for rebates between 10 and 40 percent based on the volume of the drugs purchased over the course of one quarter.

Despite an overall drop in doctor's visits, emergency visits and hospital care, children's healthcare spending rose in 2014, according to a new report by the Health Care Cost Institute that claims rising prices bridged the gap in utilization.

Citing "well-intended" but "flawed" public policy that led doctors to treat pain more aggressively, Stack advised physicians to avoid prescribing opioids to patients with non-cancer pain, except in cases where the benefits are expected to outweigh the risks.

Walgreens is teaming up with Mental Health America, a nonprofit focused on the needs of those struggling with mental health issues, to launch a new initiative to increase mental health screenings and tie patients with more telehealth services.

Insurers are picking up more of the cost of prescription pain drugs, according to a study linking that trend with the rise in opioid-related deaths.

Transparency in how drug companies set pricing is needed to reform the pharmaceuticals industry, The Campaign for Sustainable Drug Pricing claims in a new series of proposals aimed at making the prescription drug marketplace more open and competitive.

The absence of more stores like CVS that are easily accessible to people in impoverished, predominantly black neighborhoods underscores Baltimore's other persistent inequities.

Blood testing startup Theranos is under investigation by the U.S. Securities and Exchange Commission and the U.S. Attorney's Office for the Northern District of California.

Third-party nonprofits promising scientific and transparent drug value assessments are gaining ground in healthcare, even as many drug manufacturers are challenging their methodologies, according to new research by the Health Research Institute.

Pharmaceutical company Warner Chilcott was sentenced Friday in U.S. District Court in Boston to pay $125 million to resolve criminal and civil liability stemming from the illegal promotion of various drugs including Actonel, Asacol, Atelvia, Doryx, Enablex, Estrace, Loestrin and various formulations of these drugs, the U.S. Attorney's Office announced Friday.